BBAuthors: AbdelMassih, Antoine; Advisor: -; Participants: Agha, Hala; El-Saiedi, Sonia; El-Sisi, Amal; Shershaby, Meryam El; Gaber, Hanya; Ismail, Habiba-Allah; El-Husseiny, Nadine; Amin, Abeer Reda; ElBoraie, Aly; Ayad, Aya; Menshawey, Esraa; Sefein, Fady; Osman, Ibrahim Ihab; Moursi, Mai; Hanafy, Maram; Abdelaziz, Mariam Sherif; Arsanyous, Mariem Badr; El-Walid, Mariam Khaled-Ibn-; Tawfik, Marwa Gamal; Habib, Menna; Mansour, Mina Ehab; Khattab, Mohamed Ayman; Ashraf, Mirette; Fouda, Raghda (2022)
Many lives were lost since the emergence of COVID-19 (coronavirus disease 2019) pandemic in China 2019. The resultant global health crisis has compelled health authorities all over the world to allow emergency authorization to many vaccines before full FDA (Food and drug agency) approval. However, a major setback of such emergency authorization was the rise of unexpected complications. 
